Surrogate marker of preclinical tuberculosis in human immunodeficiency virus infection: Antibodies to an 88-kDa secreted antigen of Mycobacterium tuberculosis

Journal of Infectious Diseases

Volumn 176, Issue 1, 1997, Pages 133-143

  Laal, Suman ^a   Samanich, Karen M ^b   Sonnenberg, Michael G ^b   Belisle, John T ^b   O'Leary, Jeanne ^b   Simberkoff, Michael S ^b   Zolla Pazner, Susan ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY;

ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOBLOTTING; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RISK ASSESSMENT; TUBERCULIN TEST;

EID: 0030941384     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514015     Document Type: Article

References (14)

1. Raviglione MC, Narain JP, Kochi A. HIV-associated tuberculosis in developing countries: clinical features, diagnosis, and treatment. Bull World Health Organ 1992;70:515-26.
2. Harries AD. Tuberculosis and human immunodeficiency virus infection in developing countries. Lancet 1990;335:387-90.
3. Raviglione MC, Snider DE, Kochi A. Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA 1995;273: 220-6.
4. Shafer RW, Edlin BR. Tuberculosis in patients infected with human immunodeficiency virus: perspective on the past decade. Clin Infect Dis 1996; 22:683-704.
5. Barnes PF, Bloch AB, Davidson PT, Snider DE Jr. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991; 324:1644-50.
6. Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989;320:545-50.
7. Graham NM, Nelson KE, Soloman L, et al. Prevalence of tuberculin positivity and skin test anergy in HIV-1 -seropositive and -seronegative intravenous drug users. JAMA 1991;267:369-73.
8. Huebner RE, Schein MF, Hall CA, Barnes SA. Delayed-type hypersensitivity anergy in human HIV-infected persons screened for infection with Mycobacterium tuberculosis. Clin Infect Dis 1994;19:26-32.
9. Huebner RE, Villarino ME, Snider DE. Tuberculin skin testing and the HIV epidemic. JAMA 1992;267:409-10.
10. Caiaffa WT, Graham NMH, Galai N, Rizzo RT, Nelson KE, Vlahov D. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection. Arch Intern Med 1995;155:21 11-7.
11. Janoff EN, Hardy WD, Smith PD, Wahl SM. Humoral recall responses in HIV infection. J Immunol 1991;147:2130-5.
12. + T lymphocytes in adults infected with human immunodeficiency virus. Clin Infect Dis 1995;21:1197-203.
13. Farber C, Yemault J, Legros F, Debruyn J, van Vooren J. Detection of anti-p32 mycobacterial IgG antibodies in patients with AIDS. J Infect Dis 1990;162:279-80.
14. Da Costa CTKA, Khanolkar-Young S, Elliot AM, Wasunna KMA, McAdam KPWJ. Immunoglobulin subclass responses to mycobacterial lipoarabinomannan in HIV-infected and non infected patients with tuberculosis. Clin Exp Immunol 1993;91:25-9.